Cptx
Founded 2021 · 49 employees on LinkedIn · 1 known investors
Find your way into Cptx
159 people in our graph share verified history with the Cptx team — schools, employers, funds. One of them is your warm intro.
Samuel Arbesmanunlockedknows Hendrik Dietz · together at Harvard Medical School (overlapped)
×5knows the team · via Harvard Medical School
×4knows the team · via Ludwig-Maximilians-Universität München
×2knows the team · via Technical University of Munich
CPTx is a genetic medicines company developing in vivo therapies using immune-silent, redosable single-stranded DNA technology. The company focuses on creating safe, durable treatments, with a lead program in CAR-T cell therapy and collaborations on novel genetic medicines.
Founders & leadership
HD
Hendrik Dietzin𝕏Scientific Co-Founder at LogicInk
Investors · 1
Frequently asked questions
- What does Cptx do?
- CPTx is a genetic medicines company developing in vivo therapies using immune-silent, redosable single-stranded DNA technology. The company focuses on creating safe, durable treatments, with a lead program in CAR-T cell therapy and collaborations on novel genetic medicines.
- Who are Cptx's investors?
- Cptx's investors include BlueYard Capital.